Data / Drug companies / Antimetabolite
Antimetabolite drugs: 3 drugs from 17 companies in the FDA NDC directory
Antimetabolite is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 25 products in this class from 17 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on December 2, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 17Companies
- 25Products
- 3Drugs by generic name
Drugs in the Antimetabolite class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Hydroxyurea | 21 | 14 |
| Floxuridine | 3 | 3 |
| Thioguanine | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Waylis Therapeutics LLC | 5 | capsule; tablet | New drug applications (NDA) | September 11, 2025 |
| H2-Pharma, LLC | 4 | capsule | New drug applications (NDA) | June 1, 2009 |
| Medunik | 2 | tablet, film coated | New drug applications (NDA) | October 15, 2020 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | September 17, 2008 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | July 23, 2013 |
| Coupler LLC | 1 | capsule | Generic drugs (ANDA) | December 2, 2025 |
| Fresenius Kabi USA, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 15, 2001 |
| Golden State Medical Supply, Inc. | 1 | capsule | Generic drugs (ANDA) | April 8, 2020 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | February 15, 2018 |
| JND Therapeutics, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 9, 2022 |
| Leading Pharma, LLC | 1 | capsule | Generic drugs (ANDA) | July 9, 2020 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | February 24, 1999 |
| Nova Laboratories, Ltd | 1 | solution | New drug applications (NDA) | April 4, 2024 |
| Par Health USA, LLC | 1 | capsule | Generic drugs (ANDA) | February 24, 1999 |
| Qilu Pharmaceutical Co., Ltd. | 1 | capsule | Generic drugs (ANDA) | March 6, 2024 |
| Somerset Therapeutics, LLC | 1 | capsule | Generic drugs (ANDA) | June 18, 2024 |
| Teva Pharmaceuticals USA, Inc. | 1 | capsule | Generic drugs (ANDA) | October 19, 1998 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 18 | 72% |
| Injection, powder, lyophilized, for solution | 3 | 12% |
| Tablet, film coated | 2 | 8% |
| Tablet | 1 | 4% |
| Solution | 1 | 4% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.